Aug 10, 2022 / 08:30PM GMT
Kyle William Rose - Canaccord Genuity Corp., Research Division - Senior Analyst
Great. Good afternoon, everybody, and welcome to the in-person version of the 42nd Annual Canaccord Genuity Global Growth Conference. I'm Kyle Rose. I'm one of the medical technology analysts here at the firm. And I'm very excited to see a pretty good room on a Wednesday afternoon. So thanks for sticking with us.
I'm joined this afternoon by Insulet. Insulet is the leader in the pay-as-you-go insulin delivery space, what we view as one of the best technology platforms in the sector in a really compelling differentiated business model. So very pleased to be joined this afternoon by Bret Christensen, the Chief Commercial Officer; as well as Dr. Trang Ly, Insulet's Medical Director. And then we've got the finance questions for Deb Gordon, who leads IR here.
So we've got a fireside chat, but I want to make this as interactive as possible. So if there are questions, please don't hesitate to raise your hand, and I'll do my best to weave them in.
But just to kind of start, there's a lot going on now that I
Insulet Corp at Canaccord Genuity Growth Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers